Belluscura is a medical device company focused on developing lightweight and portable oxygen enrichment technology. The group has announced that it has signed its fourth distribution agreement and started manufacturing the X-PLO2R, putting it firmly on track to meet its target commercial launch in Q3. The fourth distribution agreement is with a US Service disabled veteran-owned small business that deals exclusively with the US federal government in areas of veterans affairs. This follows on from ....
27 Jul 2021
Update on Distribution & Production
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Update on Distribution & Production
Belluscura PLC (BELL:LON) | 8.0 0 3.2% | Mkt Cap: 13.2m
- Published:
27 Jul 2021 -
Author:
Paul Richards | Brendan D'Souza -
Pages:
8
Belluscura is a medical device company focused on developing lightweight and portable oxygen enrichment technology. The group has announced that it has signed its fourth distribution agreement and started manufacturing the X-PLO2R, putting it firmly on track to meet its target commercial launch in Q3. The fourth distribution agreement is with a US Service disabled veteran-owned small business that deals exclusively with the US federal government in areas of veterans affairs. This follows on from ....